EUROAPI

Equities

EAPI

FR0014008VX5

Pharmaceuticals

Real-time Euronext Paris 05:28:01 2024-04-25 am EDT 5-day change 1st Jan Change
2.698 EUR +0.45% Intraday chart for EUROAPI +4.25% -52.91%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Euroapi Names New Chief Commercial Officer MT
Euroapi: tightening of executive committee CF
Euroapi S.A. Announces Executive and Executive Committee Changes CI
CAC40: ends in green, approaches 8200 points CF
CAC40: +0.3%, tops out at 8,180, same gap for US indices CF
CAC40: records in sight 48 hours before end of 1st quarter CF
Euroapi: Kopernik Global Investors crosses the 5% threshold CF
CAC40: falls back to equilibrium at the end of the session, +1.7% over the week CF
EUROAPI : Oddo lowers its target price CF
Euroapi: share price falls 16% after Brindisi shutdown CF
CAC40: 4 witches outperform, W-Street struggles CF
CAC40: clings to 8,200 for the '4 Witches' despite rates CF
CAC40: cautious trend before a salvo of statistics CF
CAC40: Slightly negative bias ahead of the 4 witches' day CF
Euroapi: production suspended in Brindisi CF
Euroapi Halts Pharmaceutical Ingredient Production at Italian Site Amid Quality Control Issues MT
Deutsche Bank Downgrades Euroapi to Sell from Hold, Cuts PT MT
EUROAPI : Deutsche Bank downgrades to 'sell CF
Euroapi: further decline, Deutsche Bank concerned CF
CAC40: closes at half-mast despite morning record CF
Nexity: crisis measures stepped up, share price falls CF
Euroapi: transformation program and new CEO CF
Euroapi: sharply widened net loss in 2023 CF
Euroapi S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Euroapi: MAK Capital One exceeds 5% threshold CF
Chart EUROAPI
More charts
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 6 production sites located in France (2), the United Kingdom, Germany, Italy and Hungary.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
2.686 EUR
Average target price
4.72 EUR
Spread / Average Target
+75.73%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EAPI Stock
  4. News EUROAPI
  5. Euroapi Plans EUR40 Million Investment For New Production Technology For Vitamin B12